Nabriva Therapeutics plc Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 5 rows, 5 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-08-11: Reporting owner Schroeder Theodore R; Form 4; Security Stock Appreciation Right; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2022-08-11: Reporting owner Gelone Steven P.; Form 4; Security Stock Appreciation Right; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2022-08-11: Reporting owner Naftzger J. Christopher; Form 4; Security Stock Appreciation Right; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2022-08-11: Reporting owner Dolan Daniel; Form 4; Security Stock Appreciation Right; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-08-11 | Schroeder Theodore R Director, Officer (Chief Executive Officer) | 4 | Stock Appreciation Right Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +239,800 239,800 owned after | $0.45 exercise price | 2022-08-15 | |
| 2022-08-11 | Gelone Steven P. Director, Officer (President and COO) | 4 | Stock Appreciation Right Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +93,400 93,400 owned after | $0.45 exercise price | 2022-08-15 | |
| 2022-08-11 | Naftzger J. Christopher Officer (General Counsel and Corp Sec) | 4 | Stock Appreciation Right Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +63,200 63,200 owned after | $0.45 exercise price | 2022-08-15 | |
| 2022-08-11 | Dolan Daniel Officer (Chief Financial Officer) | 4 | Stock Appreciation Right Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +83,200 83,200 owned after | $0.45 exercise price | 2022-08-15 | |
| 2022-08-11 | Guico-Pabia Christine J. Officer (Chief Medical Officer) | 4 | Stock Appreciation Right Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +71,500 71,500 owned after | $0.45 exercise price | 2022-08-15 |